Free Trial
→ Nobody Understands Why Trump Is Invading Iran (here’s the answer) (From Banyan Hill Publishing) (Ad)tc pixel Free RVMD Stock Alerts

Revolution Medicines (RVMD) Short Interest Ratio & Short Volume

Revolution Medicines logo
$141.81 -0.70 (-0.49%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$141.70 -0.11 (-0.08%)
As of 05/8/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Revolution Medicines Short Interest Overview

As of April 15, 2026, Revolution Medicines (RVMD) had a short interest of 13.39 million shares sold short, representing 7.36% of the public float. This marks a -13.12% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.0, meaning it would take 3.0 days of the average trading volume of 4.76 million shares to cover all short positions.

Current Short Interest
13,387,469 shares
Previous Short Interest
15,409,530 shares
Change Vs. Previous Month
-13.12%
Dollar Volume Sold Short
$2.04 billion
Short Interest Ratio
3.0 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
212,600,000 shares
Short Percent of Float
7.36%
Today's Trading Volume
2,514,320 shares
Average Trading Volume
4,757,287 shares
Today's Volume Vs. Average
53%
Short Selling Revolution Medicines?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Revolution Medicines and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

RVMD Short Interest Over Time

RVMD Days to Cover Over Time

RVMD Percentage of Float Shorted Over Time

Revolution Medicines Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202613,387,469 shares $2.04 billion -13.1%7.4%3.04 $152.54
3/31/202615,409,530 shares $1.50 billion +6.6%8.5%7.93 $97.25
3/13/202614,457,743 shares $1.37 billion +2.4%7.9%7.77 $94.86
2/27/202614,113,308 shares $1.44 billion +3.4%7.8%5.37 $102.02
2/13/202613,655,708 shares $1.32 billion +4.5%7.7%6.9 $96.31
1/30/202613,072,474 shares $1.27 billion -8.0%7.4%3.28 $96.95
1/15/202614,216,021 shares $1.75 billion -7.2%8.0%2.02 $123.27
12/31/202515,314,358 shares $1.22 billion +1.6%8.6%6.52 $79.65
12/15/202515,070,669 shares $1.19 billion -10.3%8.5%6.8 $79.00
11/28/202516,792,419 shares $1.31 billion -4.0%9.5%8.18 $77.78
11/14/202517,485,484 shares $1.18 billion -3.0%9.9%6.42 $67.75
10/31/202518,022,242 shares $1.06 billion -6.9%10.2%7.94 $58.84
10/15/202519,360,000 shares $959.48 million +7.7%11.3%9.4 $49.56
9/30/202517,970,000 shares $839.20 million -0.4%N/A9.2 $46.70
9/15/202518,050,000 shares $833.91 million +9.2%N/A7.6 $46.20
8/31/202516,530,000 shares $627.64 million +8.9%9.6%7.4 $37.97
8/15/202515,180,000 shares $551.34 million +9.0%N/A6.7 $36.32
7/31/202513,930,000 shares $519.17 million +2.0%8.1%6.2 $37.27
7/15/202513,660,000 shares $516.48 million -15.2%N/A6 $37.81
6/30/202516,100,000 shares $592.32 million -11.3%9.4%6.8 $36.79
6/15/202518,160,000 shares $737.11 million -1.1%10.6%9.3 $40.59
5/31/202518,360,000 shares $734.03 million -2.8%11.9%10 $39.98
5/15/202518,880,000 shares $744.63 million +14.1%12.2%10.4 $39.44
4/30/202516,550,000 shares $668.29 million +0.7%N/A9.6 $40.38
4/15/202516,430,000 shares $596.74 million +1.4%10.6%10.7 $36.32
3/31/202516,200,000 shares $572.83 million -2.7%10.5%10.6 $35.36
3/15/202516,650,000 shares $651.35 million +5.1%10.8%12.6 $39.12
2/28/202515,840,000 shares $645.32 million +6.2%10.2%10.5 $40.74
2/15/202514,920,000 shares $606.80 million -6.2%9.6%9.9 $40.67
1/31/202515,910,000 shares $683.33 million -4.1%N/A10.1 $42.95
1/15/202516,590,000 shares $662.94 million +1.8%N/A10 $39.96
12/31/202416,290,000 shares $712.52 million -1.6%N/A10.4 $43.74
12/15/202416,550,000 shares $744.92 million +2.4%N/A10.7 $45.01
11/30/202416,160,000 shares $934.86 million -1.2%N/A10.6 $57.85
11/15/202416,350,000 shares $901.38 million -9.9%N/A13.7 $55.13
10/31/202418,140,000 shares $970.49 million +8.9%N/A15.9 $53.50
10/15/202416,660,000 shares $816.17 million +2.0%N/A16.3 $48.99
9/30/202416,340,000 shares $741.02 million -4.8%N/A12.9 $45.35
9/15/202417,170,000 shares $750.33 million +4.0%N/A12.5 $43.70
8/31/202416,510,000 shares $703.82 million -2.0%N/A12.1 $42.63
8/15/202416,840,000 shares $732.88 million +4.3%N/A11.5 $43.52
7/31/202416,140,000 shares $736.63 million +2.4%N/A10.7 $45.64
7/15/202415,760,000 shares $724.96 million -2.1%N/A10.4 $46.00
6/30/202416,090,000 shares $624.45 million +3.7%N/A11.8 $38.81
6/15/202415,520,000 shares $599.38 million +4.8%N/A12.4 $38.62
5/31/202414,810,000 shares $567.67 million +14.5%N/A10.6 $38.33
5/15/202412,940,000 shares $509.71 million +3.3%N/A8.7 $39.39
4/30/202412,530,000 shares $467.12 million +0.3%N/A8.5 $37.28
4/15/202412,490,000 shares $443.89 million +4.1%N/A8.7 $35.54
3/31/202412,000,000 shares $386.76 million -26.8%N/A8.9 $32.23
3/15/202416,400,000 shares $522.01 million -4.4%N/A11.5 $31.83
2/29/202417,150,000 shares $505.58 million +1.1%N/A12.2 $29.48
2/15/202416,960,000 shares $499.98 million +0.1%N/A12.8 $29.48
1/31/202416,950,000 shares $470.36 million +6.7%N/A11.9 $27.75
1/15/202415,880,000 shares $452.58 million -1.9%N/A7.8 $28.50
12/31/202316,190,000 shares $464.33 million +9.0%N/A6.5 $28.68
12/15/202314,850,000 shares $395.46 million +4.4%N/A5.7 $26.63
11/30/202314,220,000 shares $331.75 million -12.5%N/A5.7 $23.33
11/15/202316,250,000 shares $346.78 million +14.1%N/A6.7 $21.34
10/31/202314,240,000 shares $281.95 million +31.0%N/A6.1 $19.80
10/15/202310,870,000 shares $325.12 million -0.4%N/A5.1 $29.91
9/30/202310,910,000 shares $301.99 million -16.9%N/A8.6 $27.68
9/15/202313,130,000 shares $417.01 million +1.0%N/A12.4 $31.76
8/31/202313,000,000 shares $441.61 million +8.5%N/A12.5 $33.97
8/15/202311,980,000 shares $367.79 million +8.1%N/A11.3 $30.70
7/31/202311,080,000 shares $290.85 million -5.7%N/A10.6 $26.25
7/15/202311,750,000 shares $313.26 million -0.3%N/A13.3 $26.66
6/30/202311,780,000 shares $315.12 million +7.3%N/A12.5 $26.75
6/15/202310,980,000 shares $276.04 million +5.9%N/A11 $25.14
5/31/202310,370,000 shares $258.52 million +9.9%N/A10.4 $24.93
5/15/20239,440,000 shares $250.54 million -1.9%N/A7.7 $26.54
4/30/20239,620,000 shares $225.97 million -5.7%N/A7.8 $23.49
4/15/202310,200,000 shares $225.83 million -6.0%N/A8.2 $22.14
3/31/202310,850,000 shares $235.01 million +12.7%N/A8.4 $21.66
3/15/20239,630,000 shares $221.30 million +31.6%N/A7.8 $22.98
2/28/20237,320,000 shares $195.88 million -2.8%N/A5.9 $26.76
2/15/20237,530,000 shares $192.32 million +5.0%10.8%7.6 $25.54
1/31/20237,170,000 shares $191.73 million -10.7%10.5%7.3 $26.74
1/15/20238,030,000 shares $241.62 million -1.2%11.8%8.5 $30.09
12/30/20228,130,000 shares $193.66 million -6.2%11.9%8.6 $23.82
12/15/20228,670,000 shares $208.17 million -4.1%12.7%9.4 $24.01
11/30/20229,040,000 shares $213.25 million -6.9%13.3%9.8 $23.59
11/15/20229,710,000 shares $209.83 million -1.8%14.3%11.8 $21.61
10/31/20229,890,000 shares $200.37 million +1.0%14.6%12.1 $20.26
10/15/20229,790,000 shares $180.23 million -13.6%14.8%11.1 $18.41
9/30/202211,330,000 shares $223.43 million +13.1%17.1%11.8 $19.72
9/15/202210,020,000 shares $207.21 million +1.5%15.2%10.6 $20.68
8/31/20229,870,000 shares $205.59 million +2.1%15.1%10.7 $20.83
8/15/20229,670,000 shares $249.87 million +9.5%15.6%10.2 $25.84
7/31/20228,830,000 shares $199.47 million -18.5%15.4%9.3 $22.59
7/15/202210,840,000 shares $252.57 million -3.0%18.8%12.4 $23.30
6/30/202211,180,000 shares $217.90 million +21.4%22.4%15.3 $19.49
6/15/20229,210,000 shares $157.68 million -1.0%18.3%11.8 $17.12
5/31/20229,300,000 shares $157.91 million +9.3%18.5%13.2 $16.98
5/15/20228,510,000 shares $133.35 million +10.4%17.0%12.5 $15.67
4/30/20227,710,000 shares $153.97 million +4.5%15.5%11.8 $19.97
4/15/20227,380,000 shares $177.78 million -23.3%14.9%12 $24.09
3/31/20229,620,000 shares $245.41 million -0.6%19.4%14.9 $25.51
3/15/20229,680,000 shares $177.14 million -0.3%19.4%18.1 $18.30
2/28/20229,710,000 shares $183.71 million +7.8%19.2%19 $18.92
2/15/20229,010,000 shares $199.75 million +7.9%17.8%18.2 $22.17
1/31/20228,350,000 shares $179.69 million +9.7%15.6%17.2 $21.52
1/15/20227,610,000 shares $199.46 million -7.5%13.3%15.7 $26.21
12/31/20218,230,000 shares $207.15 million -11.2%N/A0 $25.17
12/15/20219,270,000 shares $238.52 million -3.4%16.2%20.2 $25.73
11/30/20219,600,000 shares $265.54 million -0.9%16.8%20.5 $27.66
11/15/20219,690,000 shares $307.95 million +0.8%17.0%21.4 $31.78
10/29/20219,610,000 shares $282.82 million -2.1%16.8%18.7 $29.43
10/15/20219,820,000 shares $264.65 million -4.7%17.2%18.8 $26.95
9/30/202110,300,000 shares $283.35 million +4.4%18.0%19.9 $27.51
9/15/20219,870,000 shares $302.22 million -0.7%17.3%16.8 $30.62
8/31/20219,940,000 shares $289.15 million +2.5%17.4%16.8 $29.09
8/13/20219,700,000 shares $247.93 million -2.1%17.0%14.4 $25.56
7/30/20219,910,000 shares $283.82 million -0.2%17.4%15.8 $28.64
7/15/20219,930,000 shares $290.85 million +3.3%17.4%14 $29.29
6/30/20219,610,000 shares $305.02 million +8.3%16.8%13.3 $31.74
6/15/20218,870,000 shares $301.67 million -4.3%15.5%13.3 $34.01
5/28/20219,270,000 shares $277.27 million +5.6%16.4%14.6 $29.91
5/14/20218,780,000 shares $269.90 million +13.9%15.9%14.8 $30.74

RVMD Short Interest - Frequently Asked Questions

Short interest is the volume of Revolution Medicines shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 13,387,469 shares of RVMD short. 7.36% of Revolution Medicines' shares are currently sold short. Learn More on Revolution Medicines' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RVMD shares currently have a short interest ratio of 3.0. Learn More on Revolution Medicines's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Revolution Medicines: Balyasny Asset Management L.P., Wells Fargo & Company MN, Jane Street Group LLC, Group One Trading LLC, Simplex Trading LLC, and Goldman Sachs Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.36% of Revolution Medicines' floating shares are currently sold short.

Revolution Medicines saw a decline in short interest in April. As of April 15th, there was short interest totaling 13,387,469 shares, a decline of 13.1% from the previous total of 15,409,530 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.36% of Revolution Medicines' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Revolution Medicines: Sanofi (0.32%), GSK PLC Sponsored ADR (0.85%), Takeda Pharmaceutical Co. (0.33%), argenex SE (3.76%), Teva Pharmaceutical Industries Ltd. (4.07%), BeOne Medicines Ltd. - Sponsored ADR (1.13%), Insmed, Inc. (6.56%), BioNTech SE Sponsored ADR (1.58%), Roivant Sciences Ltd. (3.83%), Moderna, Inc. (16.87%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

Short selling RVMD is an investing strategy that aims to generate trading profit from Revolution Medicines as its price is falling. RVMD shares are trading down $0.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Revolution Medicines occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RVMD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVMD, twice per month. The most recent reporting period available is April, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like RVMD:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:RVMD) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
A little-known stock pick with money-doubling potential over the next year is revealed for free in the first t...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel